Whitaker Anne Clem
Director at ICLR; Director at Keenova Therapeutics plc; Director at WOLF
- Sold, on record
- $2.2M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Aug 11, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- ICLRICON PLCDirector
- Keenova Therapeutics plcDirector
- WOLFWOLFSPEED, INC.Director
Sales by reason
Form 4 sales per year, every sale on record.
Sales by company
- WOLF32,489 shares
- Keenova Therapeutics plc21,087 shares
- ICLR841 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale WOLFPlan not statedJan 22, 2015 2015
Sold 624 shares at $35.09 ($22k)
Whitaker Anne Clem, Director
Sold 6.1% of holdings ($358k position)9,568 shares leftFirst sale on recordFiling
- 2 Form 4 sale WOLFPlan not statedSep 3, 2015 +224 days
Sold 1,994 shares at $26.74 ($53k)
Whitaker Anne Clem, Director
Sold 12.3% of holdings ($434k position)14,248 shares leftFiling
- 3 Form 4 sale WOLFPlan not statedFeb 16, 2016 +166 days
Sold 623 shares at $30.00 ($19k)
Whitaker Anne Clem, Director
Sold 4.4% of holdings ($427k position)13,625 shares leftFiling
- 4 Form 4 sale WOLFUnusualNov 5, 2020 +1724 days
Sold 29,248 shares at $67.94 ($2M)
Whitaker Anne Clem, Director
Sold 72.2% of holdings ($2.8M position)11,274 shares leftFirst sale on recordFiling
- 5 Form 4 sale Keenova Therapeutics plcUnusualNov 6, 2020 +1 day
Sold 21,087 shares at $0.13 ($3k)
Whitaker Anne Clem, Director
Sold 100% of holdings ($3k position)0 shares leftFirst sale on recordFiling
- 6 Form 144 notice ICLRNoticeAug 11, 2026 +2104 days
Filed to sell 841 shares ($138k)
Whitaker Anne Clem, Director
No 10b5-1 planFirst sale on recordFiling
- 7 Form 4 sale ICLRUnusualAug 11, 2026 same day
Sold 841 shares at $164.29 ($138k)
Whitaker Anne Clem, Director
No 10b5-1 planSold 48.6% of holdings ($285k position)891 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Aug 12, 2026 | ICLR | Director | Form 4 sale | 841 | $138k | 48.6% | Unusual | SEC |
| Aug 11, 2026 | Aug 11, 2026 | ICLR | Director | Form 144 notice | 841 | $138k | Notice | SEC | |
| Nov 6, 2020 | Nov 10, 2020 | Keenova Therapeutics plc | Director | Form 4 sale | 21,087 | $3k | 100.0% | Unusual | SEC |
| Nov 5, 2020 | Nov 6, 2020 | WOLF | Director | Form 4 sale | 29,248 | $2M | 72.2% | Unusual | SEC |
| Feb 16, 2016 | Feb 18, 2016 | WOLF | Director | Form 4 sale | 623 | $19k | 4.4% | Plan not stated | SEC |
| Sep 3, 2015 | Sep 3, 2015 | WOLF | Director | Form 4 sale | 1,994 | $53k | 12.3% | Plan not stated | SEC |
| Jan 22, 2015 | Jan 23, 2015 | WOLF | Director | Form 4 sale | 624 | $22k | 6.1% | Plan not stated | SEC |